# Study of Quadrivalent Influenza Vaccine Among Adults

> **NCT01218646** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 739 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Investigational Quadrivalent Inactivated Influenza Vaccine, No Preservative
- **BIOLOGICAL:** Investigational Trivalent Inactivated Influenza Vaccine, No Preservative
- **BIOLOGICAL:** Fluzone®: 2010-2011 Trivalent Inactivated Influenza Vaccine, No Preservative
- **BIOLOGICAL:** Fluzone®: 2010-2011 Trivalent Inactivated Influenza Vaccine, No Preservative

## Key facts

- **NCT ID:** NCT01218646
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 739 (ACTUAL)
- **Last updated:** 2013-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01218646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01218646, "Study of Quadrivalent Influenza Vaccine Among Adults". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01218646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*